The top news stories from Latin America

Provided by AGP

Latin American Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin American Newswire.

Press releases published on May 6, 2026

Bullish acquière Equiniti auprès de Siris dans le cadre d’une transaction de 4,2 milliards de dollars, créant ainsi un agent de transfert mondial pour les titres tokenisés
Bullish תרכוש את Equiniti מ-Siris בעסקה של 4.2 מיליארד דולר, וכך תיצור סוכנות העברות גלובליות של אסימוני ניירות ערך
Bullish akan mengakuisisi Equiniti dari Siris dalam transaksi senilai $4,2 miliar, menciptakan agen transfer global untuk sekuritas yang ditokenisasi
ブリッシュ、シリスからエクイニティを42億ドル (約6630億円) で買収し、トークン化証券向けのグローバルトランスファーエージェントを構築
Bullish, Siris로부터 Equiniti를 42억 달러에 인수하며 토큰화 증권 위한 글로벌 명의개서대리인 구축
Bullish akan memperoleh Equiniti daripada Siris dalam transaksi bernilai $4.2 bilion, mewujudkan ejen pemindahan global bagi sekuriti tokenisasi
Bullish เข้าซื้อกิจการ Equiniti จาก Siris ในธุรกรรมมูลค่า 4.2 พันล้านดอลลาร์…
Bullish 将以 42 亿美元收购 Siris 旗下 Equiniti,打造代币化证券全球过户代理机构
Bullish adquire Equiniti da Siris em transação de US$ 4,2 bilhões, criando agente de transferência global para títulos tokenizados
Bullish 將以 42 億美元向 Siris 收購 Equiniti,以建立全球代幣化證券過戶代理機構
Entrepreneur Educational Center Inc. (EECI) Empowers Future Divers with Professional Scuba Gear at Historic Dive N’ Surf
Patria Announces First Quarter 2026 Investor Call
Hercules Metals Increases Previously Announced Bought Deal Financing and Concurrent Private Placement to C$31.5 Million
Minor Hotels Announces Anantara’s Caribbean Debut in Turks and Caicos
Bitget Wallet Expands Crypto Card Availability Across Africa
BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle
Where Executives Are Doubling Down on Their Companies’ Fortunes
Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease

Share us

on your social networks:

Sign up for:

Latin American Newswire

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.